Login

Thinkific Labs Inc., a publicly traded company on the TSX , owns the trademark Thinkific. 00:10:00

Share On Facebook Share On Twitter

Greg Smith BCom, LLB, Chief Executive Officer, Co-Founder of Thinkific

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Current Economic Challenges and Investment Strategies | Matt Kabaker, Senior Managing director, Centerbridge Partners.
00:10:00
Invests in companies that transforms the quality of living for aging consumers|Alan Patricof,Chairperson,Primetime Partners
00:10:00
Insights from Aptos Biosciences CEO on Drug Development and Healthcare Systems at Blum Burton Conference | William Rice, CEO, Aptose Biosciences Inc .
00:10:00
investing from the earliest seeds of startup life to businesses scaling for growth|Ben Savage,Partner,Clocktower Technology Ventures
00:10:00
Excelling in West African Gold Mining: The Yaramoko Goldmine Story
00:10:00
Ari Kahn and John Murcott Explore AI's Impact on Search and Merchandising | Ari Kahn, CEO , Bridgeline Digital Inc.
00:10:00
BBVA's Strong Performance in First 9 Months of 2023 | Onur Genç , CEO , BBVA .
00:10:00
Introduction to Partners in Financial Planning: Salem, VA
00:10:00
Pioneering Debt Solutions: Insights from Tina Vandersteel of GMO | Head of Emerging Country Debt, GMO
00:10:00
Osisko Metals CEO Discusses Major Project Updates and Positive Outlook for Copper Market
00:10:00
Unlocking Wealth: A Behavioral Approach with Kim Curtis
00:10:00
The Difference Between a Financial Advisor and Wealth Manager with Michael Gold, CEO of Gold Family Wealth

© 2017 - Neuhu+